UY23929A1 - Procedimiento de preparacion de derivados del indol - Google Patents

Procedimiento de preparacion de derivados del indol

Info

Publication number
UY23929A1
UY23929A1 UY23929A UY23929A UY23929A1 UY 23929 A1 UY23929 A1 UY 23929A1 UY 23929 A UY23929 A UY 23929A UY 23929 A UY23929 A UY 23929A UY 23929 A1 UY23929 A1 UY 23929A1
Authority
UY
Uruguay
Prior art keywords
indole
preparation
derivatives
aminoethyl
boron hydride
Prior art date
Application number
UY23929A
Other languages
English (en)
Spanish (es)
Inventor
Duran Carles Puig
Forner Dolors Fernandez
Original Assignee
Almirall Prodesfarma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Prodesfarma Sa filed Critical Almirall Prodesfarma Sa
Publication of UY23929A1 publication Critical patent/UY23929A1/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
UY23929A 1994-03-09 1995-03-09 Procedimiento de preparacion de derivados del indol UY23929A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9400481A ES2084560B1 (es) 1994-03-09 1994-03-09 Procedimiento de preparacion de derivados el indol.

Publications (1)

Publication Number Publication Date
UY23929A1 true UY23929A1 (es) 1995-03-21

Family

ID=8285486

Family Applications (1)

Application Number Title Priority Date Filing Date
UY23929A UY23929A1 (es) 1994-03-09 1995-03-09 Procedimiento de preparacion de derivados del indol

Country Status (6)

Country Link
BR (1) BR9500821A (fi)
CO (1) CO4340738A1 (fi)
EG (1) EG20611A (fi)
ES (1) ES2084560B1 (fi)
FI (1) FI116837B (fi)
UY (1) UY23929A1 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007013098A1 (en) * 2005-07-25 2007-02-01 Matrix Laboratories Limited A process for the preparation of almotriptan
EP2774605A1 (en) 2013-02-06 2014-09-10 Galenicum Health S.L. Pharmaceutical composition comprising almotriptan malate having uniform drug distribution and potency
CN106478484B (zh) * 2016-08-31 2017-11-10 重庆华森制药股份有限公司 一种制备阿莫曲坦关键中间体的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197996A (en) * 1980-08-12 1985-08-16 Glaxo Group Ltd 1-(3-(omega-aminoalkyl)-1h-indol-5-yl)alkanamides
GB8332437D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
ES2033578B1 (es) * 1991-06-06 1995-01-16 Quimica Sint S A Con El 50 Procedimiento para la obtencion de 3-(2-(dimetilamino)etil)-n-metil-1h-indol-5-metanosulfonamida.
ES2033577B1 (es) * 1991-06-06 1995-01-16 Quimica Sint S A Con El 50 Procedimiento para la obtencion de la 2-carboxi-3-(2-(dimetilamino)etil)-n-metil-1h-indol-5-metanosulfonamida y sus esteres alquilicos inferiores.

Also Published As

Publication number Publication date
EG20611A (en) 1999-09-30
FI951047A (fi) 1995-09-10
ES2084560A1 (es) 1996-05-01
FI951047A0 (fi) 1995-03-07
CO4340738A1 (es) 1996-07-30
BR9500821A (pt) 1995-11-21
FI116837B (fi) 2006-03-15
ES2084560B1 (es) 1997-01-16

Similar Documents

Publication Publication Date Title
KR100545435B1 (ko) 인돌린 유도체 및 5-ｈｔ2 수용체 리간드로서의 이들의 용도
RU2382031C2 (ru) 3-амино-1-арилпропилиндолы, применяемые в качестве ингибиторов обратного захвата моноаминов
IE58122B1 (en) An indole derivative
IL176111A (en) Derivatives 2– (H1– indulisulphenyl) –benzyl amine as SSRI
JPH09508137A (ja) セロトニンアゴニストおよびアンタゴニストとしての４−インドール誘導体
NZ231855A (en) Heterocyclylalkyl - substituted piperazine derivatives and pharmaceutical compositions
MEP45408A (en) 6-position substituted indoline, production and use thereof as a medicament
EP1771415B1 (en) 2- (1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence
RU2132683C1 (ru) Применение производных индола в качестве 5hti агонистов
EA200300266A1 (ru) Новые сложные эфиры апорфина и их применение в терапии
NZ197998A (en) 5-amino(methyl)-1h-indol-3-ylalkaneamines
IL97426A (en) Pharmaceutical preparations, for the use of intraocular pressure in glaucoma, containing metamorphic indoles, and some new compounds from the left
JPH08504786A (ja) ５−ｈｔ▲下１▼様アゴニスト用トリプタミンアナログ
UY23929A1 (es) Procedimiento de preparacion de derivados del indol
ATE307133T1 (de) Hexahydroazepino(4,5-g)indole und -indoline als 5-ht-rezeptor-liganden
Bishop et al. New 5-HT2C receptor agonists
NO321697B1 (no) Indol derivater
Macor et al. 5-[(3-Nitropyrid-2-yl) amino] indoles: Novel serotonin agonists with selectivity for the 5-HT1D receptor. Variation of the C3 substituent on the indole template leads to increased 5-HT1D receptor selectivity
EP1331935B1 (en) Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
JPH04505923A (ja) インデノインドール化合物２
ES2206326T3 (es) Piranoindoles para tratar el glaucoma.
US7618967B2 (en) Indane compounds
Benington et al. Synthesis of O-and N-methylated derivatives of 5-hydroxytryptamine
US7629473B2 (en) 2-(1H-indolylsulfanyl)-aryl amine derivatives
EP1860100B1 (en) 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI

Legal Events

Date Code Title Description
VENC Patent expired

Effective date: 20141115